推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Pharmacogenomics & Personalized Medicine

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 PHARMACOGEN PER最新评论:审稿好像比较慢,修改后编辑直接接收了,好像没有返给审稿人 (2022-01-05)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Pharmacogenomics & Personalized Medicine期刊基本信息Hello,您是该期刊的第15587位访客

基本信息 登录收藏
期刊名字Pharmacogenomics & Personalized MedicinePharmacogenomics & Personalized Medicine

PHARMACOGEN PERS MED
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.8
51人评分
我要评分

声誉
7.1

影响力
4.7

速度
7.0

期刊ISSN1178-7066
微信扫码收藏此期刊
2023-2024最新影响因子
(数据来源于搜索引擎)
1.8 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:1.389
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子1.9
JCI期刊引文指标 0.56
h-index 暂无h-index数据
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
3.300.5080.544
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q3199 / 313
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q3134 / 178

期刊简介
Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling
Genetics and drug metabolism
Targeted drug identification and discovery
Optimizing drug selection & dosage based on patient's genetic profile
Drug related morbidity & mortality intervention
Advanced disease screening and targeted therapeutic intervention
Genetic based vaccine development
Patient satisfaction and preference
Health economic evaluations
Practical and organizational issues in the development and implementation of personalized medicine programs.
期刊官方网站https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal
期刊投稿网址https://www.dovepress.com/submit_step_1.php
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Pharmacogenomics & Personalized Medicine的语言要求,还能让Pharmacogenomics & Personalized Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Pharmacogenomics & Personalized Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD3300; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:genomic profiling、genetics、pharmacology、drug metabolism
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
出版商Dove Medical Press
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Molecular Medicine
出版国家或地区New Zealand
出版语言English
出版周期
出版年份0
年文章数 93点击查看年文章数趋势图
Gold OA文章占比98.46%
研究类文章占比:
文章 ÷(文章 + 综述)
86.02%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ3240/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ3215/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
PHARMACOLOGY & PHARMACY
药学
2区2区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区4区
PHARMACOLOGY & PHARMACY
药学
3区3区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区2区
PHARMACOLOGY & PHARMACY
药学
1区2区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7066%5BISSN%5D
平均审稿速度网友分享经验:
16 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD3300; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Pharmacogenomics & Personalized Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Pharmacogenomics & Personalized Medicine期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Pharmacogenomics & Personalized Medicine中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Pharmacogenomics & Personalized Medicine上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Journal for ImmunoTherapy of Cancer3617.70
    Biomarker Research015.80
    Cell Chemical Biology16614.70
    Molecular Biomedicine06.30
    Molecular Oncology6312.60
    VIROLOGICA SINICA209.30
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE011.50
    Biotechnology Journal708.90
    Frontiers in Genetics615.50
    Advances in Biological Regulation08.90
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677700
    BIOMATERIALS567285
    BIOMEDICINE & PHARMACOTHERAPY552018
    Frontiers in Pharmacology515786
    Journal of Materials Chemistry B506974
    Frontiers in Immunology492571
    COMPUTERS IN BIOLOGY AND MEDICINE474436
    JOURNAL OF ETHNOPHARMACOLOGY466711
    COLLOIDS AND SURFACES B-BIOINTERFACES438831
    Frontiers in Oncology436521
  •  

    Pharmacogenomics & Personalized Medicine Pharmacogenomics & Personalized Medicine
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation

    Author: Zhong, Lan; Yin, Rutie; Song, Liang
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 195-200. DOI: 10.2147/PGPM.S397827
        PubMed      DOI
    2.Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma

    Author: Zheng, Chunlan; Peng, Yanan; Wang, Haizhou; Wang, Youwei; Liu, Lan; Zhao, Qiu
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 39-58. DOI: 10.2147/PGPM.S397892
        PubMed      DOI
    3.NOTCH2, ATIC, MRI1, SLC6A13, ATP13A2 Genetic Variations are Associated with Ventricular Septal Defect in the Chinese Tibetan Population Through Whole-Exome Sequencing

    Author: Zhang, Xiaohui; Zhen, Da; Li, Xuemei; Yi, Faling; Zhang, Zhanhao; Yang, Wei; Li, Xuguang; Sheng, Yemeng; Liu, Xiaoli; Jin, Tianbo; He, Yongjun
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 389-400. DOI: 10.2147/PGPM.S404438
        PubMed      DOI
    4.The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

    Author: Zeng, Jiajia; Han, Linyu; Wang, Teng; Huang, Linying; Zheng, Yanxiu; Zhang, Nasha; Li, Ziqiang; Yang, Ming
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 229-238. DOI: 10.2147/PGPM.S402115
        PubMed      DOI
    5.LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation

    Author: Yuan, Yuan; Yu, Peng; Shen, Huihua; Xing, Guozhu; Li, Wu
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 99-109. DOI: 10.2147/PGPM.S396866
        PubMed      DOI
    6.Dysregulation of circRNA-0076906 and circRNA-0134944 is Correlated with Susceptibility to Osteoporosis and Osteoporotic Fracture in Postmenopausal Females from the Chinese Han Population

    Author: Yang, Weijie; Zhang, Wei; Li, Fengqian; Xu, Ning; Sun, Ping
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 183-194. DOI: 10.2147/PGPM.S394757
        PubMed      DOI
    7.Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report

    Author: Wu, Yining; Ou, Shenjian; Liao, Xiwen; Han, Chuangye; Yang, Chengkun; Qin, Wei; Tan, Yufeng; Lao, Quan; Peng, Tao; Ye, Xinping
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 111-120. DOI: 10.2147/PGPM.S376596
        PubMed      DOI
    8.Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report

    Author: Wu, Yan; Liu, Shan; Wang, Dongmei; Yao, Xinjie
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 401-405. DOI: 10.2147/PGPM.S407940
        PubMed      DOI
    9.Apolipoprotein E Gene Polymorphism Effects on Lipid Metabolism and Risk of Cerebral Infarction in Northwest Han Chinese Population

    Author: Wang, Yaqi; Yang, Shuang; Zhang, Suya; Lu, Xiaoyu; Ma, Wenbing
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 303-312. DOI: 10.2147/PGPM.S404663
        PubMed      DOI
    10.High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

    Author: Wang, Xuegang; Li, Weiquan; Lou, Ning; Han, Weiwei; Hai, Bo; Xiao, Wen; Zhang, Xiaoping
    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 1-14. DOI: 10.2147/PGPM.S382843
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室